BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36066065)

  • 21. Determination of a positive response in the Ames Salmonella mutagenicity assay.
    Zeiger E
    Environ Mol Mutagen; 2023 Apr; 64(4):250-258. PubMed ID: 36916210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity of white grape juice in the Ames test.
    Patrineli A; Clifford MN; Walker R; Ioannides C
    Food Chem Toxicol; 1996 Jun; 34(6):559-62. PubMed ID: 8690316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A large comparison of integrated SAR/QSAR models of the Ames test for mutagenicity
    Benfenati E; Golbamaki A; Raitano G; Roncaglioni A; Manganelli S; Lemke F; Norinder U; Lo Piparo E; Honma M; Manganaro A; Gini G
    SAR QSAR Environ Res; 2018 Aug; 29(8):591-611. PubMed ID: 30052064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of structure-activity relationship and artificial intelligence systems to improve in silico prediction of ames test mutagenicity.
    Mazzatorta P; Tran LA; Schilter B; Grigorov M
    J Chem Inf Model; 2007; 47(1):34-8. PubMed ID: 17238246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity assessment of two potential impurities in preparations of 5-amino-2,4,6 triiodoisophthalic acid, a key intermediate in the synthesis of the iodinated contrast agent iopamidol.
    Rossi S; Bussi S; Bonafè R; Incardona C; Vurro E; Visigalli M; Buonsanti F; Fretta R
    Mutat Res Genet Toxicol Environ Mutagen; 2024 Jan; 893():503720. PubMed ID: 38272634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
    Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
    Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing machine-learning models for mutagenicity prediction through better feature selection.
    Shinada NK; Koyama N; Ikemori M; Nishioka T; Hitaoka S; Hakura A; Asakura S; Matsuoka Y; Palaniappan SK
    Mutagenesis; 2022 Oct; 37(3-4):191-202. PubMed ID: 35554560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A promising Ames battery for mutagenicity characterization of new dyes.
    Umbuzeiro GA; Morales DA; Vacchi FI; Albuquerque AF; Szymczyk M; Sui X; Vinueza N; Freeman HS
    Environ Mol Mutagen; 2021 Jan; 62(1):52-65. PubMed ID: 33252143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of the Ames RAMOS test allows for a reproducible high-throughput mutagenicity test.
    Kauffmann K; Werner F; Deitert A; Finklenburg J; Brendt J; Schiwy A; Hollert H; Büchs J
    Sci Total Environ; 2020 May; 717():137168. PubMed ID: 32084684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dosing determines mutagenicity of hydrophobic compounds in the Ames II assay with metabolic transformation: passive dosing versus solvent spiking.
    Smith KE; Heringa MB; Uytewaal M; Mayer P
    Mutat Res; 2013 Jan; 750(1-2):12-8. PubMed ID: 22989744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests.
    Jin J; Liu B; Zhang H; Tian X; Cai Y; Gao P
    BMC Complement Altern Med; 2009 Nov; 9():43. PubMed ID: 19912670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Silico Prediction of Chemically Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2022; 2425():149-183. PubMed ID: 35188632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenicity Evaluation of Nanoparticles by the Ames Assay.
    Pan X
    Methods Mol Biol; 2021; 2326():275-285. PubMed ID: 34097276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the mutagenic potential of chemicals in tobacco products using
    Goel R; Valerio LG
    Toxicol Mech Methods; 2020 Nov; 30(9):672-678. PubMed ID: 32752976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying the toxic and mutagenic activity of complex mixtures with Salmonella typhimurium.
    Somani SM; Schaeffer DJ; Mack JO
    J Toxicol Environ Health; 1981; 7(3-4):643-53. PubMed ID: 7026798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could deep learning in neural networks improve the QSAR models?
    Gini G; Zanoli F; Gamba A; Raitano G; Benfenati E
    SAR QSAR Environ Res; 2019 Sep; 30(9):617-642. PubMed ID: 31460798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Ames Salmonella/microsome mutagenicity assay.
    Mortelmans K; Zeiger E
    Mutat Res; 2000 Nov; 455(1-2):29-60. PubMed ID: 11113466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Transition State Modeling To Predict Mutagenicity for Michael Acceptors.
    Allen TEH; Grayson MN; Goodman JM; Gutsell S; Russell PJ
    J Chem Inf Model; 2018 Jun; 58(6):1266-1271. PubMed ID: 29847119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.